Evidence map›Paper›PMID 32774688›Full record

ReviewAmerican journal of translational research2020

Photothermal therapy technology of metastatic colorectal cancer.

Junji Chen, Ziwei Zeng, Liang Huang, Shuangling Luo, Jianghui Dong, Fiona H Zhou, Kun Zhou, Liping Wang, Liang Kang

Open access · greenAbstract readReview
PubMed Full text at PMC
In one paragraph

Review in American journal of translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Application of phototherapeutic-based nanoparticles in colorectal cancer.International journal of biological sciences · 2021
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Junji ChenDepartment of Colorectal Surgery, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-Sen University Guangzhou 510655, Guangdong, China.
Ziwei ZengDepartment of Colorectal Surgery, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-Sen University Guangzhou 510655, Guangdong, China.
Liang HuangDepartment of Colorectal Surgery, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-Sen University Guangzhou 510655, Guangdong, China.
Shuangling LuoDepartment of Colorectal Surgery, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-Sen University Guangzhou 510655, Guangdong, China.
Jianghui DongUniSA Clinical and Health Sciences, and UniSA Cancer Research Institute, University of South Australia Adelaide, SA 5001, Australia.
Fiona H ZhouSchool of Medicine, University of Adelaide Adelaide, SA 5000, Australia.
Kun ZhouUniSA Clinical and Health Sciences, and UniSA Cancer Research Institute, University of South Australia Adelaide, SA 5001, Australia.
Liping WangUniSA Clinical and Health Sciences, and UniSA Cancer Research Institute, University of South Australia Adelaide, SA 5001, Australia.
Liang KangDepartment of Colorectal Surgery, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital of Sun Yat-Sen University Guangzhou 510655, Guangdong, China.
Sun Yat-sen University · CNUniversity of South Australia · AUThe University of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is one of the most common malignancies. The current treatments of metastatic colorectal cancer (mCRC) are ineffective and the bottleneck problem. It is of significance to explore effective new therapeutic strategies to eradicate mCRC. Photothermal therapy (PTT) is an emerging technology for tumor therapy, with the potential in the treatment of mCRC. In this review, the current treatment approaches to mCRC including surgery, radiotherapy, chemotherapy interventional therapy, biotherapy, and photothermal therapy are reviewed. In addition, we will focus on the various kinds of nanomaterials used in PTT for the treatment of CRC both in vitro and in vivo models. In conclusion, we will summarize the combined application of PTT with other theranostic methods, and propose future research directions of PTT in the treatment of CRC.

Indexed as

colorectal cancercolorectal carcinomaMucinous adenocarcinomaphotothermal therapy

Identifiers

PMID32774688
PMCPMC7407689
OpenAlexW3049309420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.